Acta neurochirurgica
-
Acta neurochirurgica · Nov 2007
Randomized Controlled TrialErythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
Erythropoietin (EPO) is neuroprotective in experimental models of stroke and subarachnoid haemorrhage (SAH) and possibly in patients with thromboembolic stroke. We studied the efficacy and safety of EPO in patients with SAH. ⋯ Beneficial effects of EPO in patients with SAH cannot be excluded or concluded on the basis of this study and larger scale trials are warranted.